bio2rdf
/
clinical-trials
/
Login
Register
TriplyDB
Clinical Trials
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
NCT00122629
NCT00122629
https://clinicaltrials.gov/show/NCT00122629
Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non Responders [clinicaltrials:NCT00122629]
url [clinicaltrials_vocabulary:url]
NCT00122629
https://clinicaltrials.gov/show/NCT00122629